Table 2 Antimicrobial susceptibility pattern of eyelid and conjunctiva isolates
Bacterial isolates | Antimicrobial drugs | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Oxa1 | Chlr2 | Erth3 | Gent4 | Tetra5 | Cipro6 | Vanco7 | Strep8 | Poly9 | Tobra10 | ||
CoNS, n (%) | S | 62 (68.1) | 64 (70.3) | 56 (61.5) | 72 (79.1) | 38 (41.8) | 69 (75.8) | 91 (100) | 61(67.0) | 63 (69.2) | 68 (74.7) |
N =91 | R | 29 (31.9) | 27 (29.7) | 35 (38.5) | 19 (20.9) | 53 (58.2) | 22 (24.2) | 0 (0.0) | 30 (33.0) | 28 (30.8) | 23 (25.3) |
S. aureus , n (%) | S | 21 (72.4) | 21(72.4) | 20 (69.0) | 20 (69.0) | 13 (44.8) | 21 (72.4) | 29 (100) | 28 (96.6) | 28 (96.6) | 24 (82.8) |
N = 29 | R | 8 (27.6) | 8 (27.6) | 9 (31.0) | 9 (31.0) | 16 (55.2) | 8 (27.6) | 0 (0.0) | 1 (3.4) | 1 (3.4) | 5 (17.2) |
Others*, n (%) | S | 1 (83.3) | 10 (55.6) | 1 (25.0) | 17 (94.4) | 15 (83.3) | 16 (88.9) | 4 (100) | 15 (83.3) | 14 (77.8) | 14 (77.8) |
N = 18 | R | 3 (16.7) | 8 (44.4) | 3 (75.0) | 1 (5.6) | 3 (16.7) | 2 (11.1) | 0 (0.0) | 3 (16.7) | 4 (22.2) | 4 (22.2) |